• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因造血干细胞移植后终末分化调节性 T 细胞比例高。

High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.

机构信息

Hematology Research Unit, Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA)-I³, University of Liège, Liège, Belgium.

Division of Hematology, Department of Medicine, CHU of Liège, Liège, Belgium.

出版信息

Bone Marrow Transplant. 2021 Aug;56(8):1828-1841. doi: 10.1038/s41409-021-01221-0. Epub 2021 Mar 4.

DOI:10.1038/s41409-021-01221-0
PMID:33664462
Abstract

It is now well-established that regulatory T cells (Treg) represent a heterogeneous group of CD4 T cells. Previous studies have demonstrated that Treg homeostasis was impacted by allogeneic hematopoietic cell transplantation (allo-HCT) and particularly so in patients with chronic graft-versus-host disease (GVHD). Here, we first assessed the ability of various Treg subsets to phosphorylate STAT5 in response to IL-2 or IL-7 stimulation in vitro. We then compared the frequencies of different Treg subtypes in healthy controls as well as in allo-HCT patients with or without chronic GVHD. The highest phosphorylated STAT5 (pSTAT5) signal in response to IL-2 was observed in the CD45ROCD26CD39HLA-DR Treg fraction. In contrast, naive Treg were mostly less susceptible to IL-2 stimulation in vitro. Following IL-7 stimulation, most Treg subpopulations upregulated pSTAT5 expression but to a lesser extent than conventional T cells. Compared to healthy controls, allo-HCT patients had lower frequencies of the naive CD45RACD26 Treg subpopulation but higher frequencies of the most differentiated memory CD45ROCD26CD39 Treg subpopulations. Further, unbiased analysis revealed that six Treg clusters characterized by high expression of CD25, HLA-DR, and ICOS were significantly more frequent in patients with no or with limited chronic GVHD than in those with moderate/severe chronic GVHD.

摘要

现在已经明确,调节性 T 细胞(Treg)代表了一组异质性的 CD4 T 细胞。先前的研究表明,Treg 稳态受到异基因造血细胞移植(allo-HCT)的影响,在慢性移植物抗宿主病(GVHD)患者中尤其如此。在这里,我们首先评估了各种 Treg 亚群在体外对 IL-2 或 IL-7 刺激的磷酸化 STAT5 的能力。然后,我们比较了健康对照者以及有无慢性 GVHD 的 allo-HCT 患者中不同 Treg 亚型的频率。对 IL-2 的最高磷酸化 STAT5(pSTAT5)信号出现在 CD45ROCD26CD39HLA-DR Treg 亚群中。相比之下,幼稚 Treg 在体外对 IL-2 刺激的敏感性较低。在 IL-7 刺激后,大多数 Treg 亚群上调了 pSTAT5 的表达,但程度低于常规 T 细胞。与健康对照者相比,allo-HCT 患者的幼稚 CD45RACD26 Treg 亚群频率较低,但最分化的记忆 CD45ROCD26CD39 Treg 亚群频率较高。此外,无偏分析表明,六个 Treg 簇具有高表达 CD25、HLA-DR 和 ICOS 的特征,在无或有限慢性 GVHD 的患者中比在中度/重度慢性 GVHD 的患者中更为频繁。

相似文献

1
High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后终末分化调节性 T 细胞比例高。
Bone Marrow Transplant. 2021 Aug;56(8):1828-1841. doi: 10.1038/s41409-021-01221-0. Epub 2021 Mar 4.
2
[Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].供体CD4+CD25+调节性T细胞对异基因造血干细胞移植后造血与免疫重建、移植物抗宿主病及无病生存的影响
Nan Fang Yi Ke Da Xue Xue Bao. 2008 Apr;28(4):537-41.
3
Naive and Stem Cell Memory T Cell Subset Recovery Reveals Opposing Reconstitution Patterns in CD4 and CD8 T Cells in Chronic Graft vs. Host Disease.幼稚和干细胞记忆 T 细胞亚群的恢复揭示了慢性移植物抗宿主病中 CD4 和 CD8 T 细胞重建的相反模式。
Front Immunol. 2019 Mar 6;10:334. doi: 10.3389/fimmu.2019.00334. eCollection 2019.
4
CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.同种异体干细胞移植后恶性肿瘤复发后 CTLA-4 阻断与 T 细胞激活相关,但与 T 调节细胞水平升高无关。
Biol Blood Marrow Transplant. 2011 May;17(5):682-92. doi: 10.1016/j.bbmt.2010.08.005. Epub 2010 Aug 14.
5
Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.第三方脐带血来源的调节性 T 细胞可预防异种移植物抗宿主病。
Cytotherapy. 2014 Jan;16(1):90-100. doi: 10.1016/j.jcyt.2013.07.009. Epub 2013 Oct 26.
6
Advanced flowcytometric analysis of regulatory T cells: CD127 downregulation early post stem cell transplantation and altered Treg/CD3(+)CD4(+)-ratio in severe GvHD or relapse.高级流式细胞术分析调节性 T 细胞:干细胞移植后早期 CD127 下调,以及严重 GvHD 或复发时 Treg/CD3(+)CD4(+)比值改变。
J Immunol Methods. 2011 Oct 28;373(1-2):36-44. doi: 10.1016/j.jim.2011.07.018. Epub 2011 Aug 3.
7
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.在异基因干细胞移植后,CD4+CD25+FOXP3+调节性T细胞在多发性骨髓瘤患者的骨髓中重建并积聚。
Haematologica. 2008 Mar;93(3):423-30. doi: 10.3324/haematol.11897. Epub 2008 Feb 20.
8
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.用于调节性T细胞抑制小鼠移植物抗宿主病的供体要求
J Immunol. 2015 Jul 1;195(1):347-55. doi: 10.4049/jimmunol.1402861. Epub 2015 May 20.
9
Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.与粒细胞集落刺激因子(G-CSF)预处理的外周血移植物相比,G-CSF预处理的骨髓移植物中调节性T细胞的频率更高。
J Transl Med. 2015 May 7;13:145. doi: 10.1186/s12967-015-0507-z.
10
Impact of low-dose anti-thymocyte globulin on immune reconstitution after allogeneic hematopoietic cell transplantation.低剂量抗胸腺细胞球蛋白对异基因造血细胞移植后免疫重建的影响。
Int J Hematol. 2020 Jan;111(1):120-130. doi: 10.1007/s12185-019-02756-1. Epub 2019 Oct 22.

引用本文的文献

1
[Biological activity and antitumor effect of long-acting recombinant human interleukin-2 drug].长效重组人白细胞介素-2药物的生物学活性及抗肿瘤作用
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Apr 18;57(2):253-261. doi: 10.19723/j.issn.1671-167X.2025.02.005.
2
Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice.人源化小鼠实验性移植物抗宿主病的病理生理学及临床前相关性
Biomark Res. 2024 Nov 14;12(1):139. doi: 10.1186/s40364-024-00684-9.
3
Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells.

本文引用的文献

1
IL-2 enhances ex vivo-expanded regulatory T-cell persistence after adoptive transfer.白细胞介素-2可增强过继转移后体外扩增的调节性T细胞的持久性。
Blood Adv. 2020 Apr 28;4(8):1594-1605. doi: 10.1182/bloodadvances.2019001248.
2
The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus.2018年欧洲血液和骨髓移植协会造血细胞移植与细胞治疗活动调查:嵌合抗原受体T细胞疗法备受关注。
Bone Marrow Transplant. 2020 Aug;55(8):1604-1613. doi: 10.1038/s41409-020-0826-4. Epub 2020 Feb 17.
3
Control of Regulatory T Cells by Co-signal Molecules.
移植后环磷酰胺可预防异种移植物抗宿主病,同时消耗增殖性调节性T细胞。
iScience. 2023 Jan 31;26(3):106085. doi: 10.1016/j.isci.2023.106085. eCollection 2023 Mar 17.
调控性 T 细胞的共刺激信号分子控制。
Adv Exp Med Biol. 2019;1189:179-210. doi: 10.1007/978-981-32-9717-3_7.
4
The promise of CD4FoxP3 regulatory T-cell manipulation : applications for allogeneic hematopoietic stem cell transplantation.CD4FoxP3 调节性 T 细胞操纵的前景:同种异体造血干细胞移植的应用。
Haematologica. 2019 Jul;104(7):1309-1321. doi: 10.3324/haematol.2018.198838. Epub 2019 Jun 20.
5
The γ Family of Cytokines: Basic Biology to Therapeutic Ramifications.γ 细胞因子家族:基础生物学与治疗相关性。
Immunity. 2019 Apr 16;50(4):832-850. doi: 10.1016/j.immuni.2019.03.028.
6
Functional analysis of clinical response to low-dose IL-2 in patients with refractory chronic graft-versus-host disease.低剂量白细胞介素-2 治疗难治性慢性移植物抗宿主病患者的临床反应功能分析。
Blood Adv. 2019 Apr 9;3(7):984-994. doi: 10.1182/bloodadvances.2018027474.
7
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease.体外光化学疗法联合白细胞介素-2治疗慢性移植物抗宿主病的疗效及免疫效应。
Blood Adv. 2019 Apr 9;3(7):969-979. doi: 10.1182/bloodadvances.2018029124.
8
Microenvironment tailors nTreg structure and function.微环境塑造了 nTreg 的结构和功能。
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6298-6307. doi: 10.1073/pnas.1812471116. Epub 2019 Mar 7.
9
Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia.白血病造血干细胞移植后的移植物抗白血病效应
Front Immunol. 2017 Jun 7;8:496. doi: 10.3389/fimmu.2017.00496. eCollection 2017.
10
Pathophysiology of GvHD and Other HSCT-Related Major Complications.移植物抗宿主病及其他造血干细胞移植相关主要并发症的病理生理学
Front Immunol. 2017 Mar 20;8:79. doi: 10.3389/fimmu.2017.00079. eCollection 2017.